DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 114 filers reported holding DYNE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,799,000 | -62.0% | 220,400 | -37.0% | 0.05% | -29.7% |
| Q2 2021 | $7,364,000 | +35.5% | 350,000 | 0.0% | 0.07% | +45.1% |
| Q1 2021 | $5,436,000 | -26.0% | 350,000 | 0.0% | 0.05% | -20.3% |
| Q4 2020 | $7,350,000 | +4.0% | 350,000 | 0.0% | 0.06% | -28.1% |
| Q3 2020 | $7,067,000 | – | 350,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |